PSG is recognized as the industry’s pre-eminent thought leader producing insightful relevant content to help you address today’s pharmaceutical environment. Through our cutting-edge client engagements, our experts offer foresight that shape the market.
PSG’s RxWire is a weekly publication highlighting key FDA approvals, clinical research, and top industry articles. Each week, our experts collect information on government regulation, pharmaceutical trends, and trending news to help you anticipate how the changing market landscape could impact your organization.
As new drugs reach FDA approval, it's important to know how they can impact your plan and your members. PSG offers In the Know to keep you informed as new medications hit the market. This timely update provides detailed drug descriptions, pricing information and specific recommendations.